Metraipolis › archive › dc_56d733cb9814
Case report and literature review: tislelizumab combined with lenvatinib and polymeric micellar paclitaxel for thymic squamous cell carcinoma — Europe PMC PMID:41050702
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41050702
- DOI
- 10.3389/fimmu.2025.1677723
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T21:21:56.852Z
- SHA-256 of the archived text
a207da68215e44c54c775b4c2774bd2d2aac9f0eef6f051e3e7ec3018d1792ec- Stable URL of this page
https://metraipolis.com/documento/dc_56d733cb9814
How to cite
Case report and literature review: tislelizumab combined with lenvatinib and polymeric micellar paclitaxel for thymic squamous cell carcinoma — Europe PMC PMID:41050702 — Europe PMC (en), https://europepmc.org/article/MED/41050702 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_56d733cb9814 (Metraipolis archive dc_56d733cb9814, sha256 a207da68215e44c54c775b4c2774bd2d2aac9f0eef6f051e3e7ec3018d1792ec)
BibTeX
@misc{dc56d733cb9814,
title = {Case report and literature review: tislelizumab combined with lenvatinib and polymeric micellar paclitaxel for thymic squamous cell carcinoma — Europe PMC PMID:41050702},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41050702},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_56d733cb9814; sha256 a207da68215e44c54c775b4c2774bd2d2aac9f0eef6f051e3e7ec3018d1792ec},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41050702. Agents can read the archived copy with the MCP tool read_document.